Subcommittee on Oversight and Investigations
Bart Stupak (MI), Chairman
Subcommittee Jurisdiction: Responsibility for oversight of agencies, departments, and programs within the jurisdiction of the full committee, and for conducting investigations within such jurisdiction.
Members (Ratio: 9-7):
Bart Stupak, MI, Chairman |
John Shimkus, IL, Ranking Member* |
|
|
Charlie Melancon, LA, Vice Chair
|
|
|
|
|
|
|
|
|
Joe Barton, TX (Ex Officio)
|
|
|
John D. Dingell (Ex Officio)
|
|
*Membership changes are based on a Resolution offered by Rep. Barton on Dec. 13, 2007, before the Committee on Energy and Commerce that the Republican membership of the standing subcommittees of the Committee for the 110th Congress be changed as reflected in the list above.
Hearings and Markups:
See Legislative Activity Hearings and Markups
Investigations:
See Investigations for information specific to each current investigation.
Statements of Chairman Bart Stupak:
- July 31, 2008, Hearing "The Recent Salmonella Outbreak: Lessons Learned and Consequences to Industry and Public Health"
- July 24, 2008, Hearing "Long-term Care Insurance: Are Consumers Protected For the Long Term?
- May 22, 2008, Hearing "Germs, Viruses, and Secrets: Government Plans to Move Exotic Disease Research to the Mainland United States"
- May 15, 2008, Hearing "In the Hands of Strangers: Are Nursing Home Safeguards Working?"
- May 8, 2008, Hearing "Direct-to-Consumer Advertising: Marketing, Education or Deception?"
- April 22, 2008, Hearing "FDA's Foreign Drug Inspection Program: Weaknesses Place Americans at Risk"
- April 4, 2008, Hearing "Selling the Department of Energy’s Depleted Uranium Stockpile: Opportunities and Challenges"
- March 12, 2008, Hearing "Regulatory Failure: Must America Live with Unsafe Food?"
- February 26, 2008, Hearing "Contaminated Food: Private Sector Accountability"
- February 12, 2008, Hearing "Ketek Clinical Study Fraud: What Aventis Knew"
- January 29, 2008, Hearing "Science and Mission at Risk: FDA’s Self-Assessment"
- January 23, 2008, Hearing "Combating Nuclear Proliferation: The Effectiveness of the Department of Energy's Initiatives for Proliferation Prevention (IPP) Program"
- December 12, 2007, Hearing "Energy Speculation: Is Greater Regulation Necessary to Stop Price Manipulation?
- November 1, 2007, Hearing "FDA Foreign Drug Inspection Program: A System at Risk"
- October 24, 2007, Hearing "NASPER: Why Has the National All Schedules Prescription"
Electronic Reporting Act Not Been Implemented?
- October 11, 2007, Hearing "Diminished Capacity: Can the FDA Assure the Safety and Security of the Nation's Food Supply? - Part III"
- October 4, 2007, Hearing “Germs, Viruses, and Secrets: The Silent Proliferation of Bio-Laboratories in the United States”
- September 18, 2007, Hearing “Nuclear Terrorism Prevention: Status Report on the Federal Government’s Assessment of New Radiation Detection Monitors”
- August 1, 2007, Hearing "Post-Katrina Healthcare in the New Orleans Region: Progress and Continuing Concerns Part II"
- July 17, 2007, Hearing "Diminished Capacity: Can the FDA Assure the Safety and Security of the Nation's Food Supply? - Part 2"
- June 26, 2007, Hearing "Predatory Sales Practices in Medicare Advantage"
- June 12, 2007, Hearing "Poisoned Patriots: Contaminated Drinking Water at Camp Lejeune"
- May 22, 2007, Hearing "Gasoline Prices, Oil Profits, and the American Consumer"
- May 16, 2007, Hearing "2006 Prudhoe Bay Shutdown: Will Recent Regulatory Changes and BP Management Reforms Prevent Future Failures?"
- April 24, 2007, Hearing "Diminished Capacity: Can the FDA Assure the Safety and Security of the Nation's Food Supply"
- April 20, 2007, Hearing "DOE's Response to Ongoing Mismanagement at the Los Alamos National Labs"
- March 22, 2007, Hearing "The Adequacy of the FDA Efforts to Assure the Safety of the Drug Supply Part II"
- March 13, 2007, Hearing Post Katrina Health Care: Continuing Concerns and Immediate Needs in the New Orleans Region, March 13, 2007 and Referenced Photos: 1, 2, 3, and 4
- February 13, 2007, Hearing "The Adequacy of the FDA to Assure the Safety of the Drug Supply"
- Business Meeting to Issue Subpoenas Relating to the FDA Oversight Hearing
- January 30, 2007, Hearing "Continuing Security Concerns at Los Alamos National Laboratory"
|